Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 30 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atlas Therapeutics Corp | 38,916,562 | reported | 16 Jun 2023 | tx 6+176,842,715 |
| Lifesci Acquisition II Corp. | 19,849,217 | reported | 23 May 2022 | tx 1+40,983 |
| ARRAY BIOPHARMA INC | 19,150,650 | reported | 20 Jan 2016 | tx 8+2,057,492 |
| Malo Holdings Corp | 16,421,788 | reported | 14 Jun 2024 | tx 5+6,014,841 |
| ADC Therapeutics SA | 15,734,267 | reported | 11 Jun 2025 | tx 26+44,287,439−79,686 |
| Absci Corp | 8,262,136 | reported | 12 Jun 2024 | tx 8+8,104,888−4,209,573 |
| Zymeworks Inc. | 6,075,918 | reported | 13 Oct 2022 | tx 2+60,962 |
| Invivyd, Inc. | 3,390,960 | reported | 10 Aug 2021 | tx 3+3,390,960−1,920,960 |
| IGM Biosciences, Inc. | 2,964,843 | reported | 30 Jun 2025 | tx 30+8,332,747−2,026,693 |
| Aprea Therapeutics, Inc. | 1,768,718 | reported | 28 Dec 2020 | tx 5+2,268,718−1,664,674 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 8,977,624 | 0.00 USD | |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 8,977,624 | 0.00 USD | |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 3,691,324 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 3,691,324 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 266,280 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 266,280 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 162,013 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | FATE THERAPEUTICS INC | 162,013 | 0.00 USD | deriv |
| 14 Jul 2025 | GRANT_AWARD | Shattuck Labs, Inc. | 33,150 | 0.00 USD | deriv |
| 30 Jun 2025 | GRANT_AWARD | IGM Biosciences, Inc. | 828 | 0.00 USD | |
| 11 Jun 2025 | PURCHASE | ADC Therapeutics SA | 12,465,234 | 3.43 USD | deriv |
| 11 Jun 2025 | PURCHASE | ADC Therapeutics SA | 15,734,267 | 3.43 USD | derivfirst after silence |
| 29 May 2025 | GRANT_AWARD | FATE THERAPEUTICS INC | 55,000 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | IGM Biosciences, Inc. | 828 | 0.00 USD | |
| 31 Dec 2024 | GRANT_AWARD | IGM Biosciences, Inc. | 1,734 | 0.00 USD | |
| 28 Jun 2024 | GRANT_AWARD | IGM Biosciences, Inc. | 1,734 | 0.00 USD | |
| 21 Jun 2024 | GRANT_AWARD | Shattuck Labs, Inc. | 27,700 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Malo Holdings Corp | 12,879 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Absci Corp | 8,820 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Absci Corp | 36,274 | 0.00 USD | deriv |
| 08 May 2024 | PURCHASE | ADC Therapeutics SA | 8,163,265 | 4.81 USD | deriv |
| 08 May 2024 | PURCHASE | ADC Therapeutics SA | 6,107,181 | 4.81 USD | deriv |
| 28 Mar 2024 | OTHER | Shattuck Labs, Inc. | 4,425 | 0.00 USD | |
| 12 Mar 2024 | GRANT_AWARD | IGM Biosciences, Inc. | 29,400 | 0.00 USD | deriv |
| 05 Jan 2024 | PURCHASE | ADC Therapeutics SA | 50,000 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 11 Jun 2025.